Cellular and gene therapies are expected to represent one of the biggest advances in medical treatments since the introduction of monoclonal antibodies. And needless to say, there is enormous opportunity in this field for biotech companies. However, the path to developing and commercializing a cell and gene therapy product is complex and there are many hurdles to overcome. Learn more about what to look for in the right CRO partner to overcome logistical and operational challenges.
Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP ...
Other content in this Stream
Learn about the benefits that Real-World Evidence (RWE) can bring to small & mid-size biopharmaceutical companies.
Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss how biotech companies can incorporate precision medicine into their development plans.
Learn why capturing meaningful endpoints during the drug development process means a better quality of life for patients.
Collectively, rare diseases affect over 30 million Americans. The Orphan Drug Act (ODA), which provides the statutory basis for FDA to designate a drug or biologic agent as a therapy for a...
In this blog, Parexel regulatory and strategy experts tackle the question of how we can ensure that worthy innovations in the biotech pipeline make it to patients sooner.
The pharmaceutical industry is inundated with a plethora of communications about data integrity. Let's look at at one of these situations where applicant holders face these issues successfully.
Hear firsthand from Monica about her personal journey as a clinical trial participant to understand the value of easing patient burden
James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both from Parexel, discuss how Parexel Biotech has been built to meet customer and patient needs
Focused on meeting customer and the patient needs with tailored, flexible solutions that speed up development and increase the likelihood of launch so that we get treatments into the hands of patients
For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.
Learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.
Three strategies that apply multidisciplinary solutions earlier in the development process to reduce failures and accelerate CNS drug development.